Opaleye Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
4,110,000
+2,195,923
| +115% | +$6.35M | 2.4% | 11 |
|
|
2025
Q1 | $4.12M | Buy |
+1,914,077
| New | +$4.12M | 0.92% | 24 |
|
|
2024
Q2 | – | Sell |
-174,413
| Closed | -$1.32M | – | 56 |
|
|
2024
Q1 | $1.32M | Sell |
174,413
-449,087
| -72% | -$3.41M | 0.29% | 44 |
|
|
2023
Q4 | $2.84M | Sell |
623,500
-225,000
| -27% | -$1.02M | 0.75% | 32 |
|
|
2023
Q3 | $3.35M | Sell |
848,500
-541,500
| -39% | -$2.14M | 1.09% | 26 |
|
|
2023
Q2 | $4.35M | Sell |
1,390,000
-11,000
| -0.8% | -$34.4K | 1.04% | 25 |
|
|
2023
Q1 | $6.35M | Sell |
1,401,000
-159,000
| -10% | -$720K | 1.9% | 15 |
|
|
2022
Q4 | $6.44M | Sell |
1,560,000
-101,784
| -6% | -$420K | 2.24% | 13 |
|
|
2022
Q3 | $5.32M | Buy |
1,661,784
+728,970
| +78% | +$2.33M | 2.2% | 14 |
|
|
2022
Q2 | $1.83M | Sell |
932,814
-10,888
| -1% | -$21.3K | 0.82% | 31 |
|
|
2022
Q1 | $3.82M | Buy |
943,702
+60,100
| +7% | +$243K | 1.19% | 23 |
|
|
2021
Q4 | $9.53M | Buy |
883,602
+50,795
| +6% | +$548K | 2.02% | 18 |
|
|
2021
Q3 | $9.6M | Buy |
832,807
+105,007
| +14% | +$1.21M | 1.79% | 19 |
|
|
2021
Q2 | $7.15M | Buy |
+727,800
| New | +$7.15M | 1.19% | 27 |
|